CGON (CGON) Stock Price & Analysis
CGON (CGON) rose 0.46% to USD 74.67 as of September 8, 2026 at 04:23 UTC, according to Nexqual real-time market data.
CGON last closed at USD 74.67; the session ranged USD 72.87–74.88 on volume of 282,523 shares. Market capitalization is —, with a 52-week range of USD 32.08–80.97 (NMS). Source: Nexqual, September 8, 2026 at 04:23 UTC.
Key Statistics (as of September 8, 2026 at 04:23 UTC)
| Price | USD 74.67 |
|---|---|
| Change | ▲ 0.46% (up) |
| Previous Close | USD 74.67 |
| Open | USD 74.67 |
| Day Range | USD 72.87 – 74.88 |
| 52-Week Range | USD 32.08 – 80.97 |
| Volume | 282,523 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (CGON)
Nexqual's technical model rates CGON "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 04:23 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.19 (neutral) |
| vs SMA50 | Above (USD 73.66) |
| MACD | 0.57 (positive) |
From CGON's Latest SEC 10-K Filing (filed 2026-02-27)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AVBP | ArriVent BioPharma, Inc. | USD 30.95 | ▲ 1.44% |
| APGE | Apogee Therapeutics, Inc. | USD 135.07 | ▲ 0% |
| SYRE | Spyre Therapeutics, Inc. | USD 88.98 | ▲ 2.22% |
| MLYS | Mineralys Therapeutics, Inc. | USD 28.21 | ▼ 2.86% |
| EWTX | Edgewise Therapeutics, Inc. | USD 43.07 | ▲ 2.6% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:23 UTC. This page is informational and not investment advice.